BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29279493)

  • 1. Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin Type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis.
    Saburi M; Ogata M; Yoshida N; Nashimoto Y; Moroga Y; Takano K; Kohno K; Daa T; Shirao K
    Intern Med; 2018 Apr; 57(8):1145-1149. PubMed ID: 29279493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis.
    Komatsuda A; Wakui H; Nimura T; Sawada K
    Mod Rheumatol; 2008; 18(3):315-8. PubMed ID: 18368468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system other iatrogenic immunodeficiency-associated lymphoproliferative disorders presenting as extraosseous plasmacytoma with a progressive clinical course: A case report and literature review.
    Ohgaki F; Takemoto Y; Paku S; Tatezuki J; Kumagai J; Shuto T; Mochimatsu Y
    Neuropathology; 2023 Apr; 43(2):151-157. PubMed ID: 36065518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
    Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
    BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic Hodgkin lymphoma without lymphadenopathy following reversible methotrexate-associated lymphoproliferative disorder.
    Tsukazaki Y; Shinohara T; Tanaka K; Naruse K; Iwahara Y; Inoue S
    Mod Rheumatol; 2017 Mar; 27(2):372-375. PubMed ID: 25401225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
    Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
    Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iatrogenic immunodeficiency-associated Epstein-Barr virus (EBV) -negative natural killer cell lymphoproliferative disorder in a patient undergoing rheumatoid arthritis therapy].
    Uchida T; Inoue M; Hua J; Tajima S; Ota Y; Hagihara M
    Rinsho Ketsueki; 2017; 58(6):624-629. PubMed ID: 28679993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature.
    Tsuji H; Yoshifuji H; Shindo T; Hishizawa M; Ishida A; Fujimoto M; Kitagori K; Akizuki S; Murakami K; Nakashima R; Hashimoto M; Tanaka M; Ohmura K
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):172-177. PubMed ID: 32985951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
    J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Tokuhira M; Tamaru JI; Kizaki M
    J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
    Tajima S; Takanashi Y; Koda K; Fukayama M
    Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment.
    Koji H; Yazawa T; Nakabayashi K; Fujioka Y; Kamma H; Yamada A
    Mod Rheumatol; 2016; 26(2):271-5. PubMed ID: 24386983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
    Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].
    Kato T; Imaizumi Y; Itonaga H; Sato S; Ando K; Sawayama Y; Ichinose K; Miyoshi H; Ohshima K; Miyazaki Y
    Rinsho Ketsueki; 2023; 64(2):97-101. PubMed ID: 36990739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated lymphoproliferative disorder presenting with classical Hodgkin lymphoma and developing as peripheral T-cell lymphoma 9 years later: a case report of composite lymphoma.
    Oka K; Nagayama R; Iijima S; Yonekawa N; Hirosawa K; Yatabe Y; Mori N
    Pathol Int; 2011 Dec; 61(12):752-5. PubMed ID: 22126384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
    Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
    Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
    Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
    Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.